Nektar Therapeutics Cash Flow Statement
View: Annual | Quarterly
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Net Operating Cash Flow | 146.3 | (92.7) | (78.0) |
| Net Investing Cash Flow | (32.7) | (116.9) | 32.4 |
| Net Financing Cash Flow | (101.8) | 11.8 | 274.9 |
| Net Change in Cash | 12.5 | (197.5) | 229.2 |
| Depreciation & Amortization | 28.1 | 32.6 | 26.2 |
| Capital Expenditures | (32.8) | (22.5) | (18.0) |
| Cash Dividends Paid | -- | -- | -- |





